Literature DB >> 14999775

Direct injection of immature dendritic cells into irradiated tumor induces efficient antitumor immunity.

Kwang-Woon Kim1, Sun-Hee Kim, Jin-Gue Shin, Gui-Sook Kim, Young-Ok Son, Soon-Won Park, Byung-Hyun Kwon, Dong-Won Kim, Chang-Hun Lee, Mee-Young Sol, Min-Ho Jeong, Byung-Seon Chung, Chi-Dug Kang.   

Abstract

Although there are several ways to load tumor antigens to DCs, in vitro preparation of tumor antigens and manipulation of DCs are usually required. Therefore, to develop a simple antitumor immunization method, we examined if direct injection of DCs into tumor apoptosed by ionizing IR could induce efficient antitumor immunity. Ionizing IR with 15 Gy induced apoptosis in tumor maximally after 6 hr. Injection of DCs i.t. into IR tumor induced strong cytotoxicity of splenocytes against tumor cells compared to i.t. injection of DCs or ionizing IR of tumor, both of which induced weak cytotoxicity. In an animal study, i.t. injection of DCs into IR tumor induced therapeutic antitumor immunity against a tumor established at a distant site. Moreover, when TNF-alpha or LPS was added as a danger/maturation signal to DC suspension before i.t. injection, antitumor immunity was significantly potentiated compared to a group treated with i.t. injection of DCs into IR tumor. Our results suggest that injection of DCs into tumor apoptosed by ionizing IR might be a simple and efficient method of immunization against tumor. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14999775     DOI: 10.1002/ijc.20036

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  29 in total

Review 1.  Natural endogenous adjuvants.

Authors:  Kenneth L Rock; Arron Hearn; Chun-Jen Chen; Yan Shi
Journal:  Springer Semin Immunopathol       Date:  2004-10-14

Review 2.  Radiation takes its Toll.

Authors:  Josephine A Ratikan; Ewa D Micewicz; Michael W Xie; Dörthe Schaue
Journal:  Cancer Lett       Date:  2015-03-25       Impact factor: 8.679

Review 3.  Effects of irradiation on tumor cell survival, invasion and angiogenesis.

Authors:  Odysseas Kargiotis; Aliki Geka; Jasti S Rao; Athanasios P Kyritsis
Journal:  J Neurooncol       Date:  2010-05-07       Impact factor: 4.130

Review 4.  Radiation therapy and immunotherapy: what is the optimal timing or sequencing?

Authors:  Maureen L Aliru; Jonathan E Schoenhals; Bhanu P Venkatesulu; Clark C Anderson; Hampartsoum B Barsoumian; Ahmed I Younes; Lakshmi S K Mahadevan; Melinda Soeung; Kathryn E Aziz; James W Welsh; Sunil Krishnan
Journal:  Immunotherapy       Date:  2018-02-01       Impact factor: 4.196

Review 5.  Combining radiotherapy and cancer immunotherapy: a paradigm shift.

Authors:  Silvia C Formenti; Sandra Demaria
Journal:  J Natl Cancer Inst       Date:  2013-01-04       Impact factor: 13.506

Review 6.  Combination regimens of radiation therapy and therapeutic cancer vaccines: mechanisms and opportunities.

Authors:  Charlie Garnett-Benson; James W Hodge; Sofia R Gameiro
Journal:  Semin Radiat Oncol       Date:  2015-01       Impact factor: 5.934

Review 7.  The optimal partnership of radiation and immunotherapy: from preclinical studies to clinical translation.

Authors:  Sandra Demaria; Karsten A Pilones; Claire Vanpouille-Box; Encouse B Golden; Silvia C Formenti
Journal:  Radiat Res       Date:  2014-06-17       Impact factor: 2.841

Review 8.  Stereotactic Ablative Radiation Therapy Combined With Immunotherapy for Solid Tumors.

Authors:  Eric D Brooks; Jonathan E Schoenhals; Chad Tang; Goran Micevic; Daniel R Gomez; Joe Y Chang; James W Welsh
Journal:  Cancer J       Date:  2016 Jul-Aug       Impact factor: 3.360

Review 9.  Radiation as immunomodulator: implications for dendritic cell-based immunotherapy.

Authors:  Robert E Roses; Jashodeep Datta; Brian J Czerniecki
Journal:  Radiat Res       Date:  2014-07-03       Impact factor: 2.841

Review 10.  Local control by radiotherapy: is that all there is?

Authors:  Silvia C Formenti; Sandra Demaria
Journal:  Breast Cancer Res       Date:  2008-11-05       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.